Literature DB >> 32311862

Intestinal tuberculosis or Crohn's disease: a review of the diagnostic models designed to differentiate between these two gastrointestinal diseases.

Julajak Limsrivilai1, Nonthalee Pausawasdi1.   

Abstract

Differentiating Crohn's disease (CD) from intestinal tuberculosis (ITB) is a diagnostic dilemma, particularly in regions where ITB is prevalent and CD incidence is increasing, because both diseases can present quite similarly, and diagnostic tests to identify Mycobacterium tuberculosis in tissue samples have rather poor sensitivity. Studies that were conducted to determine the factors that differentiate CD from ITB identified some significant characteristics, but none of those characteristics are exclusive to either ITB or CD. Many diagnostic models or scoring systems that use one to several diagnostic parameters have been proposed to help distinguish these two intestinal diseases. Early models consisted of parameters common to routine clinical practice, such as clinical features, and endoscopic and pathologic findings. The later models also include more advanced diagnostic parameters like high-resolution imaging and serological testing. However, the number and types of parameters differ among diagnostic models, and the systems used to calculate scoring also vary from model to model. Enhanced awareness and understanding of the currently available diagnostic models will help physicians determine which model(s) is/are most suitable for differentiating CD from ITB in their clinical practice.

Entities:  

Keywords:  Crohn disease; Diagnosis; Intestinal tuberculosis

Year:  2020        PMID: 32311862     DOI: 10.5217/ir.2019.09142

Source DB:  PubMed          Journal:  Intest Res        ISSN: 1598-9100


  5 in total

1.  Validation of models using basic parameters to differentiate intestinal tuberculosis from Crohn's disease: A multicenter study from Asia.

Authors:  Julajak Limsrivilai; Choon Kin Lee; Piyapan Prueksapanich; Kamin Harinwan; Asawin Sudcharoen; Natcha Cheewasereechon; Satimai Aniwan; Pimsiri Sripongpan; Panu Wetwittayakhlang; Ananya Pongpaibul; Anapat Sanpavat; Nonthalee Pausawasdi; Phunchai Charatcharoenwitthaya; Peter D R Higgins; Siew Chien Ng
Journal:  PLoS One       Date:  2020-11-30       Impact factor: 3.240

2.  Microbial changes in stool, saliva, serum, and urine before and after anti-TNF-α therapy in patients with inflammatory bowel diseases.

Authors:  Yong Eun Park; Hye Su Moon; Dongeun Yong; Hochan Seo; Jinho Yang; Tae-Seop Shin; Yoon-Keun Kim; Jin Ran Kim; Yoo Na Lee; Young-Ho Kim; Joo Sung Kim; Jae Hee Cheon
Journal:  Sci Rep       Date:  2022-04-15       Impact factor: 4.996

Review 3.  Inflammatory bowel disease in Korea: epidemiology and pathophysiology.

Authors:  Jung Won Lee; Chang Soo Eun
Journal:  Korean J Intern Med       Date:  2022-07-29       Impact factor: 3.165

4.  Alterations of Gut Microbiota in Patients With Intestinal Tuberculosis That Different From Crohn's Disease.

Authors:  Cong He; Huan Wang; Chen Yu; Chao Peng; Xu Shu; Wangdi Liao; Zhenhua Zhu
Journal:  Front Bioeng Biotechnol       Date:  2021-07-06

5.  Fecal Calprotectin as a Surrogate Marker for Mucosal Healing After Initiating the Therapeutic Anti-Tubercular Trial.

Authors:  Satimai Aniwan
Journal:  Clin Endosc       Date:  2022-03-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.